http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2156617-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a76bfead7558381e66c9f66ec42958a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca8309b408fa2a61d18bbbcaa04e1cfa |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 |
| filingDate | 1999-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6536d53f29e9ed2ad37ce2acd0c6763 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec7fc067b17a645b8426ce7d06defff |
| publicationDate | 2000-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2156617-C1 |
| titleOfInvention | Method for treating adjuvant arthritis |
| abstract | FIELD: veterinary medicine. SUBSTANCE: method involves applying ceruloplasmin as serum enzyme antioxidant for treating rabbits. 10 mg of ceruloplasmin is solved in 1 ml of sterile physiological salt solution and injected into a joint once a week during 4-6 weeks. The preparation used is obtained from retroplacental human blood. The preparation shows curative effectiveness when treating rabbits possessing the formed adjuvant arthritis. EFFECT: enhanced effectiveness in treating animals; advised for treating the cases of rheumatoid arthritis in human patients. 2 cl |
| priorityDate | 1999-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.